FLUPHENAZINE DECANOATE

FLUPHENAZINE DECANOATE was reported 435 times

These side effects are most commonly reported by patients taking FLUPHENAZINE DECANOATE:

# Side effect Count
0 DRUG INEFFECTIVE 53
1 NEUROLEPTIC MALIGNANT SYNDROME 42
2 SEDATION 38
3 DRUG INTERACTION 35
4 AKATHISIA 32
5 PARKINSONISM 31
6 WEIGHT INCREASED 31
7 DYSTONIA 26
8 CONSTIPATION 25
9 DELUSION 25
10 ABNORMAL BEHAVIOUR 24
11 DYSKINESIA 23
12 AGGRESSION 21
13 EXTRAPYRAMIDAL DISORDER 21
14 HYPERCHOLESTEROLAEMIA 21
15 SUICIDE ATTEMPT 20
16 TREMOR 20
17 COGNITIVE DISORDER 17
18 RHABDOMYOLYSIS 17
19 DIABETES MELLITUS 16
20 ORTHOSTATIC HYPERTENSION 16
21 SCHIZOPHRENIA 16
22 TREATMENT NONCOMPLIANCE 16
23 GYNAECOMASTIA 14
24 PSYCHOTIC DISORDER 14
25 PYREXIA 14
26 TOXICITY TO VARIOUS AGENTS 14
27 HOSTILITY 13
28 SOCIAL AVOIDANT BEHAVIOUR 13
29 SUICIDAL IDEATION 13
30 VISION BLURRED 13
31 ANOSOGNOSIA 12
32 ANXIETY 12
33 BLOOD PROLACTIN ABNORMAL 12
34 EMOTIONAL POVERTY 12
35 MUSCULOSKELETAL STIFFNESS 12
36 OVERDOSE 12
37 SEXUAL DYSFUNCTION 12
38 AGITATION 11
39 APATHY 11
40 BLUNTED AFFECT 11
41 CHEST PAIN 11
42 DYSLIPIDAEMIA 11
43 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11
44 OFF LABEL USE 11
45 ADVERSE DRUG REACTION 10
46 BLOOD PROLACTIN INCREASED 10
47 GRANULOCYTOPENIA 10
48 SALIVARY HYPERSECRETION 10
49 URINARY RETENTION 10
50 CARDIAC ARREST 9
51 CONDITION AGGRAVATED 9
52 DYSPNOEA 9
53 HALLUCINATION 9
54 LETHARGY 9
55 LEUKOPENIA 9
56 CATATONIA 8
57 DIZZINESS 8
58 DYSPHAGIA 8
59 FATIGUE 8
60 GASTROINTESTINAL HAEMORRHAGE 8
61 HYPONATRAEMIA 8
62 MUSCLE RIGIDITY 8
63 TARDIVE DYSKINESIA 8
64 TREATMENT FAILURE 8
65 ACCOMMODATION DISORDER 7
66 DRUG ABUSE 7
67 DRUG EFFECT INCOMPLETE 7
68 DYSARTHRIA 7
69 FALL 7
70 FLATULENCE 7
71 HYPERTENSION 7
72 INSOMNIA 7
73 NEUTROPENIA 7
74 PSYCHIATRIC DECOMPENSATION 7
75 RESPIRATORY FAILURE 7
76 SEIZURE 7
77 TACHYCARDIA 7
78 UNDERDOSE 7
79 WEIGHT DECREASED 7
80 CAMPTOCORMIA 6
81 DIARRHOEA 6
82 GAIT DISTURBANCE 6
83 HYPERHIDROSIS 6
84 HYPOTENSION 6
85 LOSS OF CONSCIOUSNESS 6
86 MYOCARDITIS 6
87 PERFORATED ULCER 6
88 RASH PRURITIC 6
89 SOMNOLENCE 6
90 VOMITING 6
91 WITHDRAWAL SYNDROME 6
92 ABDOMINAL PAIN UPPER 5
93 ATRIAL FIBRILLATION 5
94 BLOOD CREATINE PHOSPHOKINASE INCREASED 5
95 CONVULSION 5
96 DEHYDRATION 5
97 DRUG DEPENDENCE 5
98 ELECTROCARDIOGRAM QT PROLONGED 5
99 HYPERGLYCAEMIA 5
100 METABOLIC DISORDER 5
101 MUSCLE TWITCHING 5
102 NAUSEA 5
103 OEDEMA 5
104 PAIN IN EXTREMITY 5
105 PNEUMONIA 5
106 RESTLESSNESS 5
107 SEPSIS 5
108 SUDDEN DEATH 5
109 THERAPEUTIC RESPONSE DECREASED 5
110 TYPE 2 DIABETES MELLITUS 5
111 WRONG DRUG ADMINISTERED 5
112 ACCIDENTAL OVERDOSE 4
113 ARTHRALGIA 4
114 ASTHENIA 4
115 BRADYKINESIA 4
116 CARDIO-RESPIRATORY ARREST 4
117 COMA 4
118 COUGH 4
119 DEPRESSION 4
120 DRUG INTOLERANCE 4
121 DRUG RESISTANCE 4
122 DRY MOUTH 4
123 GALACTORRHOEA 4
124 HALLUCINATION, AUDITORY 4
125 HYPERAMMONAEMIC ENCEPHALOPATHY 4
126 INJECTION SITE PAIN 4
127 LUNG DISORDER 4
128 MEDICATION ERROR 4
129 MUTISM 4
130 MYOCARDIAL INFARCTION 4
131 NEPHROGENIC DIABETES INSIPIDUS 4
132 PANCREATITIS NECROTISING 4
133 PERSONALITY CHANGE 4
134 PRODUCT DOSE OMISSION ISSUE 4
135 PRURITUS 4
136 PSYCHOMOTOR HYPERACTIVITY 4
137 PULMONARY EMBOLISM 4
138 PULMONARY OEDEMA 4
139 RENAL IMPAIRMENT 4
140 RESPIRATORY DEPRESSION 4
141 SYNCOPE 4
142 TACHYPNOEA 4
143 ABDOMINAL PAIN 3
144 AGRANULOCYTOSIS 3
145 AMNESIA 3
146 ANAEMIA 3
147 ANAL INCONTINENCE 3
148 APHASIA 3
149 ARTERIOSCLEROSIS 3
150 BLOOD TRIGLYCERIDES INCREASED 3
151 BRADYCARDIA 3
152 CARDIAC FAILURE 3
153 CIRCULATORY COLLAPSE 3
154 COMPLETED SUICIDE 3
155 CONDUCTION DISORDER 3
156 CONFUSIONAL STATE 3
157 DEATH 3
158 DECREASED APPETITE 3
159 DELIRIUM 3
160 DISTURBANCE IN ATTENTION 3
161 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
162 DYSURIA 3
163 EPILEPSY 3
164 FEELING ABNORMAL 3
165 HAEMODYNAMIC INSTABILITY 3
166 HYPERTRIGLYCERIDAEMIA 3
167 ILEUS 3
168 INTENTIONAL SELF-INJURY 3
169 IRRITABILITY 3
170 MENTAL DISORDER 3
171 MENTAL STATUS CHANGES 3
172 MOVEMENT DISORDER 3
173 NEUROMUSCULAR TOXICITY 3
174 OROPHARYNGEAL PAIN 3
175 PANCREATITIS HAEMORRHAGIC 3
176 PARANOIA 3
177 PNEUMONIA ASPIRATION 3
178 PRODUCT ADMINISTRATION ERROR 3
179 PRODUCT QUALITY ISSUE 3
180 RASH 3
181 RENAL DISORDER 3
182 SINUS TACHYCARDIA 3
183 SMALL INTESTINAL OBSTRUCTION 3
184 SUBSTANCE ABUSE 3
185 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
186 THERAPY NON-RESPONDER 3
187 THERAPY PARTIAL RESPONDER 3
188 THINKING ABNORMAL 3
189 TORSADE DE POINTES 3
190 URINARY INCONTINENCE 3
191 VISUAL ACUITY REDUCED 3
192 VISUAL IMPAIRMENT 3
193 WHITE BLOOD CELL COUNT INCREASED 3
194 ABASIA 2
195 ABDOMINAL DISCOMFORT 2
196 ACIDOSIS 2
197 ACUTE KIDNEY INJURY 2
198 ADVERSE EVENT 2
199 AFFECTIVE DISORDER 2
200 ALCOHOL USE 2
201 ALOPECIA 2
202 ALTERED STATE OF CONSCIOUSNESS 2
203 ANGER 2
204 ANTICONVULSANT DRUG LEVEL DECREASED 2
205 APPLICATION SITE ERYTHEMA 2
206 ARRHYTHMIA 2
207 BACK PAIN 2
208 BIPOLAR DISORDER 2
209 BIPOLAR I DISORDER 2
210 BLOOD CHLORIDE DECREASED 2
211 BLOOD GLUCOSE INCREASED 2
212 BLOOD PRESSURE DECREASED 2
213 BRADYPNOEA 2
214 BRAIN OEDEMA 2
215 CACHEXIA 2
216 CARDIAC FAILURE CONGESTIVE 2
217 CATARACT 2
218 CHROMATURIA 2
219 COMMUNICATION DISORDER 2
220 CONJUNCTIVITIS 2
221 COORDINATION ABNORMAL 2
222 COPROLALIA 2
223 COVID-19 2
224 DECREASED ACTIVITY 2
225 DELUSIONAL PERCEPTION 2
226 DEPRESSED MOOD 2
227 DIABETIC COMA 2
228 DIABETIC KETOACIDOSIS 2
229 DIET REFUSAL 2
230 DISEASE PROGRESSION 2
231 DISINHIBITION 2
232 DISORIENTATION 2
233 DROOLING 2
234 DRUG DOSE OMISSION 2
235 DRUG EFFECT DECREASED 2
236 DRUG LEVEL DECREASED 2
237 DRUG LEVEL INCREASED 2
238 DYSPEPSIA 2
239 DYSPHORIA 2
240 EATING DISORDER 2
241 ENCEPHALOPATHY 2
242 EXPIRED PRODUCT ADMINISTERED 2
243 FEAR 2
244 FEEDING DISORDER 2
245 FLUID INTAKE REDUCED 2
246 FOLATE DEFICIENCY 2
247 HAEMATEMESIS 2
248 HAEMATOCRIT DECREASED 2
249 HAEMOGLOBIN DECREASED 2
250 HEADACHE 2
251 HEPATITIS FULMINANT 2
252 HYPERKALAEMIA 2
253 HYPERPROLACTINAEMIA 2
254 HYPERTONIA 2
255 HYPOAESTHESIA 2
256 HYPOKALAEMIA 2
257 HYPOTHYROIDISM 2
258 HYPOXIA 2
259 INCOHERENT 2
260 INCORRECT DOSE ADMINISTERED 2
261 INCORRECT ROUTE OF DRUG ADMINISTRATION 2
262 INCREASED APPETITE 2
263 INJECTION SITE ERYTHEMA 2
264 JOINT SWELLING 2
265 KETONURIA 2
266 LEUKOCYTOSIS 2
267 LOGORRHOEA 2
268 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
269 LOWER RESPIRATORY TRACT INFECTION 2
270 MANIA 2
271 MATERNAL EXPOSURE DURING PREGNANCY 2
272 MENTAL IMPAIRMENT 2
273 METABOLIC ACIDOSIS 2
274 MOOD SWINGS 2
275 MOTOR DYSFUNCTION 2
276 MUSCULAR WEAKNESS 2
277 MYALGIA 2
278 MYOCARDIAL NECROSIS MARKER INCREASED 2
279 MYOPATHY TOXIC 2
280 NEGATIVISM 2
281 NERVOUSNESS 2
282 NEUTROPHIL COUNT DECREASED 2
283 NO THERAPEUTIC RESPONSE 2
284 OLIGOMENORRHOEA 2
285 ORTHOSTATIC HYPOTENSION 2
286 OXYGEN SATURATION DECREASED 2
287 PAIN 2
288 PALPITATIONS 2
289 PANCREATITIS 2
290 PARKINSON^S DISEASE 2
291 PERICARDITIS CONSTRICTIVE 2
292 PERSECUTORY DELUSION 2
293 PERSONALITY DISORDER 2
294 PNEUMONITIS 2
295 POLYDIPSIA 2
296 POLYURIA 2
297 PRIAPISM 2
298 PRODUCT USE IN UNAPPROVED INDICATION 2
299 RED BLOOD CELL COUNT DECREASED 2
300 REFUSAL OF TREATMENT BY PATIENT 2
301 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 2
302 SCREAMING 2
303 SELF-INJURIOUS IDEATION 2
304 SPEECH DISORDER 2
305 TENSION 2
306 THERAPEUTIC RESPONSE UNEXPECTED 2
307 TIC 2
308 TROPONIN INCREASED 2
309 UNEVALUABLE EVENT 2
310 UNRESPONSIVE TO STIMULI 2
311 VERTIGO 2
312 WHITE BLOOD CELL COUNT DECREASED 2
313 ABDOMINAL DISTENSION 1
314 ABNORMAL DREAMS 1
315 ABNORMAL SLEEP-RELATED EVENT 1
316 ACROCHORDON 1
317 ACTIVITIES OF DAILY LIVING IMPAIRED 1
318 ACUTE RESPIRATORY FAILURE 1
319 AGRAPHIA 1
320 AKINESIA 1
321 ALCOHOL POISONING 1
322 ANAEMIA MEGALOBLASTIC 1
323 ANAPHYLACTOID REACTION 1
324 ANOREXIA 1
325 ANTICONVULSANT DRUG LEVEL INCREASED 1
326 ANTISOCIAL BEHAVIOUR 1
327 APALLIC SYNDROME 1
328 APPLICATION SITE PRURITUS 1
329 ARTERIAL OCCLUSIVE DISEASE 1
330 ARTERIOSCLEROSIS CORONARY ARTERY 1
331 ARTHROPATHY 1
332 ASPHYXIA 1
333 ASPIRATION 1
334 ATRIOVENTRICULAR BLOCK COMPLETE 1
335 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 1
336 AUTOMATISM 1
337 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
338 AVERSION 1
339 AZOTAEMIA 1
340 BACTERIA URINE 1
341 BACTERIAL INFECTION 1
342 BEHAVIOUR DISORDER 1
343 BLEPHAROSPASM 1
344 BLINDNESS UNILATERAL 1
345 BLOOD CHOLESTEROL INCREASED 1
346 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1
347 BLOOD CREATININE INCREASED 1
348 BLOOD LACTATE DEHYDROGENASE INCREASED 1
349 BLOOD POTASSIUM INCREASED 1
350 BLOOD PRESSURE INADEQUATELY CONTROLLED 1
351 BLOOD SODIUM DECREASED 1
352 BLOOD UREA INCREASED 1
353 BODY MASS INDEX INCREASED 1
354 BONE MARROW DISORDER 1
355 BONE MARROW FAILURE 1
356 BONE PAIN 1
357 BRADYPHRENIA 1
358 BREAST CANCER 1
359 C-REACTIVE PROTEIN INCREASED 1
360 CARDIAC ENZYMES INCREASED 1
361 CARDIOGENIC SHOCK 1
362 CARDIOTOXICITY 1
363 CEREBROVASCULAR ACCIDENT 1
364 CHILLS 1
365 COAGULATION FACTOR DECREASED 1
366 COGWHEEL RIGIDITY 1
367 COLONIC PSEUDO-OBSTRUCTION 1
368 COMPARTMENT SYNDROME 1
369 CONGENITAL ANOMALY 1
370 CONTUSION 1
371 CORNEAL DEPOSITS 1
372 CORNEAL OEDEMA 1
373 CORNEAL PIGMENTATION 1
374 CORONARY ARTERY DISEASE 1
375 CYANOSIS 1
376 CYCLOTHYMIC DISORDER 1
377 DELUSION OF GRANDEUR 1
378 DEPENDENCE 1
379 DEREALISATION 1
380 DERMATITIS CONTACT 1
381 DIABETES INSIPIDUS 1
382 DIABETIC NEUROPATHY 1
383 DILATATION VENTRICULAR 1
384 DIPLOPIA 1
385 DISCOMFORT 1
386 DISORGANISED SPEECH 1
387 DISSOCIATION 1
388 DRUG ADMINISTERED IN WRONG DEVICE 1
389 DRUG ADMINISTRATION ERROR 1
390 DRUG DISPENSING ERROR 1
391 DRUG INTERACTION POTENTIATION 1
392 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1
393 DRUG TOLERANCE 1
394 DRUG TOXICITY 1
395 DRY SKIN 1
396 DYSGRAPHIA 1
397 DYSPNOEA EXERTIONAL 1
398 DYSSTASIA 1
399 ECZEMA 1
400 EJECTION FRACTION DECREASED 1
401 ELECTROLYTE IMBALANCE 1
402 EMBOLIA CUTIS MEDICAMENTOSA 1
403 EMOTIONAL DISTRESS 1
404 EOSINOPHILIA 1
405 ERECTILE DYSFUNCTION 1
406 EYE MOVEMENT DISORDER 1
407 EYELID OEDEMA 1
408 FAECAL INCONTINENCE 1
409 FAECALOMA 1
410 FAECES HARD 1
411 FEBRILE NEUTROPENIA 1
412 FEELING HOT 1
413 FEMORAL NECK FRACTURE 1
414 FIBROSIS 1
415 FINE MOTOR SKILL DYSFUNCTION 1
416 FLAT AFFECT 1
417 FLUSHING 1
418 FRUSTRATION 1
419 GALLBLADDER DISORDER 1
420 GENERAL PHYSICAL CONDITION ABNORMAL 1
421 GENERAL PHYSICAL HEALTH DETERIORATION 1
422 GENERALISED ANXIETY DISORDER 1
423 GENERALISED OEDEMA 1
424 GINGIVAL BLEEDING 1
425 GINGIVAL HYPERTROPHY 1
426 GRAND MAL CONVULSION 1
427 HALLUCINATION, VISUAL 1
428 HEAD DISCOMFORT 1
429 HEAD INJURY 1
430 HEART RATE INCREASED 1
431 HEMIPLEGIA 1
432 HEPATITIS 1
433 HEPATOCELLULAR DAMAGE 1
434 HOSPITALISATION 1
435 HYPERAMMONAEMIA 1
436 HYPERCOAGULATION 1
437 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1
438 HYPEROSMOLAR HYPERGLYCAEMIC STATE 1
439 HYPERSENSITIVITY 1
440 HYPERTRANSAMINASAEMIA 1
441 HYPOCALCAEMIA 1
442 HYPOGLYCAEMIA 1
443 HYPOKINESIA 1
444 HYPOMANIA 1
445 HYPOOSMOLAR STATE 1
446 HYPOPHAGIA 1
447 HYPOPROTEINAEMIA 1
448 HYPOVENTILATION 1
449 HYPOVOLAEMIA 1
450 HYSTERICAL PSYCHOSIS 1
451 IDEAS OF REFERENCE 1
452 ILL-DEFINED DISORDER 1
453 ILLNESS ANXIETY DISORDER 1
454 ILLUSION 1
455 INABILITY TO AFFORD MEDICATION 1
456 INAPPROPRIATE AFFECT 1
457 INCONTINENCE 1
458 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
459 INFECTION 1
460 INFLUENZA LIKE ILLNESS 1
461 INITIAL INSOMNIA 1
462 INJECTION SITE MASS 1
463 INTENTIONAL DRUG MISUSE 1
464 INTENTIONAL OVERDOSE 1
465 INTERNATIONAL NORMALISED RATIO INCREASED 1
466 INTESTINAL PSEUDO-OBSTRUCTION 1
467 JUDGEMENT IMPAIRED 1
468 KETOSIS 1
469 LABELLED DRUG-DRUG INTERACTION ISSUE 1
470 LACERATION 1
471 LEFT VENTRICULAR DYSFUNCTION 1
472 LENTICULAR OPACITIES 1
473 LIMB INJURY 1
474 LIVER DISORDER 1
475 LIVER INJURY 1
476 LOCALISED INFECTION 1
477 LUNG INFILTRATION 1
478 LYMPHADENOPATHY 1
479 LYMPHOCYTE COUNT DECREASED 1
480 MACULAR DEGENERATION 1
481 MACULOPATHY 1
482 MALAISE 1
483 MALNUTRITION 1
484 MARKEDLY REDUCED DIETARY INTAKE 1
485 MASTITIS 1
486 MEMORY IMPAIRMENT 1
487 MENSTRUAL DISORDER 1
488 MICTURITION DISORDER 1
489 MOBILITY DECREASED 1
490 MONOPLEGIA 1
491 MOOD ALTERED 1
492 MOUTH SWELLING 1
493 MUCOSAL INFLAMMATION 1
494 MULTIPLE DRUG OVERDOSE 1
495 MUSCLE DISORDER 1
496 MUSCLE SPASMS 1
497 MUSCLE TIGHTNESS 1
498 MUSCULOSKELETAL PAIN 1
499 MYOCARDIAL ISCHAEMIA 1
500 NASOPHARYNGITIS 1
501 NECK PAIN 1
502 NEGATIVE THOUGHTS 1
503 NEOPLASM PROGRESSION 1
504 NERVE INJURY 1
505 NERVOUS SYSTEM DISORDER 1
506 NEUROPATHY PERIPHERAL 1
507 NEUROTOXICITY 1
508 NICOTINE DEPENDENCE 1
509 NO ADVERSE EVENT 1
510 NON-SMALL CELL LUNG CANCER 1
511 OBESITY 1
512 OBSTRUCTION GASTRIC 1
513 OEDEMA PERIPHERAL 1
514 ONYCHOCLASIS 1
515 PANCREATIC HAEMORRHAGE 1
516 PANCREATITIS ACUTE 1
517 PANIC ATTACK 1
518 PAPILLOEDEMA 1
519 PARALYSIS 1
520 PARKINSON'S DISEASE 1
521 PARKINSONIAN GAIT 1
522 PAROSMIA 1
523 PATIENT DISSATISFACTION WITH TREATMENT 1
524 PATIENT ELOPEMENT 1
525 PERICARDITIS 1
526 PETIT MAL EPILEPSY 1
527 PHARMACEUTICAL PRODUCT COMPLAINT 1
528 PHARYNGEAL ERYTHEMA 1
529 PHARYNGOLARYNGEAL PAIN 1
530 PHOTOPHOBIA 1
531 PITUITARY TUMOUR BENIGN 1
532 PLATELET AGGREGATION DECREASED 1
533 PLATELET COUNT DECREASED 1
534 PLATELET COUNT INCREASED 1
535 PLEURAL EFFUSION 1
536 POISONING 1
537 POLLAKIURIA 1
538 POOR PERSONAL HYGIENE 1
539 POOR QUALITY SLEEP 1
540 PRESCRIBED OVERDOSE 1
541 PRESCRIBED UNDERDOSE 1
542 PRESSURE OF SPEECH 1
543 PRESYNCOPE 1
544 PRODUCT AVAILABILITY ISSUE 1
545 PRODUCT CONTAINER ISSUE 1
546 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
547 PRODUCT LABEL CONFUSION 1
548 PRODUCT PRESCRIBING ERROR 1
549 PRODUCT PRESCRIBING ISSUE 1
550 PRODUCT TAMPERING 1
551 PRODUCT USE ISSUE 1
552 PROSTATE INFECTION 1
553 PROTHROMBIN TIME PROLONGED 1
554 PROTRUSION TONGUE 1
555 PSYCHIATRIC SYMPTOM 1
556 PSYCHOMOTOR SKILLS IMPAIRED 1
557 PULMONARY FIBROSIS 1
558 PULMONARY INFARCTION 1
559 PUPIL FIXED 1
560 PYLORIC STENOSIS 1
561 RASH MACULAR 1
562 REBOUND PSYCHOSIS 1
563 REFUSAL OF EXAMINATION 1
564 RENAL FAILURE 1
565 RESPIRATORY ALKALOSIS 1
566 RESPIRATORY GAS EXCHANGE DISORDER 1
567 RESPIRATORY TRACT INFECTION 1
568 RESTLESS LEGS SYNDROME 1
569 RETCHING 1
570 RIGHT VENTRICULAR FAILURE 1
571 SCAR 1
572 SEBORRHOEA 1
573 SEDATION COMPLICATION 1
574 SELF-MEDICATION 1
575 SICK SINUS SYNDROME 1
576 SINUS ARRHYTHMIA 1
577 SINUSITIS 1
578 SKIN DISCOLOURATION 1
579 SKIN EXFOLIATION 1
580 SLEEP APNOEA SYNDROME 1
581 SLEEP DISORDER 1
582 SLEEP WALKING 1
583 SMOKER 1
584 SNEEZING 1
585 SOLILOQUY 1
586 SOMATIC SYMPTOM DISORDER 1
587 SOMNAMBULISM 1
588 SPINAL PAIN 1
589 STEREOTYPY 1
590 STUPOR 1
591 SUBARACHNOID HAEMORRHAGE 1
592 SUBSTANCE USE 1
593 SUICIDAL BEHAVIOUR 1
594 SWELLING OF EYELID 1
595 SYMPTOM RECURRENCE 1
596 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1
597 TACHYPHRENIA 1
598 TENDERNESS 1
599 THERAPEUTIC AGENT TOXICITY 1
600 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 1
601 THERAPEUTIC PRODUCT EFFECT DECREASED 1
602 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1
603 THERAPY INTERRUPTED 1
604 THERAPY RESPONDER 1
605 THOUGHT INSERTION 1
606 THROMBOCYTOPENIA 1
607 TOURETTE^S DISORDER 1
608 TRANSIENT ISCHAEMIC ATTACK 1
609 TRANSIENT PSYCHOSIS 1
610 UPPER GASTROINTESTINAL HAEMORRHAGE 1
611 URINARY TRACT INFECTION 1
612 URTICARIA 1
613 VASCULAR DEVICE INFECTION 1
614 VENTRICULAR TACHYCARDIA 1
615 VIRAL INFECTION 1
616 VISUAL DISTURBANCE 1
617 VON WILLEBRAND'S DISEASE 1
618 VULVOVAGINAL INJURY 1
619 WEIGHT ABNORMAL 1
620 WHEEZING 1
621 WITHDRAWAL CATATONIA 1
622 WOUND 1
623 WOUND HAEMORRHAGE 1
624 WRONG PRODUCT ADMINISTERED 1